These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33641242)

  • 1. Cardiolipin interacts with beta-2-glycoprotein I and forms an open conformation-Mechanisms analyzed using hydrogen/deuterium exchange.
    Tang KT; Wu TY; Chen HH; Lin CC; Hsu YH
    Protein Sci; 2021 May; 30(5):927-939. PubMed ID: 33641242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.
    Agar C; van Os GM; Mörgelin M; Sprenger RR; Marquart JA; Urbanus RT; Derksen RH; Meijers JC; de Groot PG
    Blood; 2010 Aug; 116(8):1336-43. PubMed ID: 20462962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses against domain I of β(2)-glycoprotein I are driven by conformational changes: domain I of β(2)-glycoprotein I harbors a cryptic immunogenic epitope.
    de Laat B; van Berkel M; Urbanus RT; Siregar B; de Groot PG; Gebbink MF; Maas C
    Arthritis Rheum; 2011 Dec; 63(12):3960-8. PubMed ID: 21898342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the N- and C-terminal domains of bovine beta 2-glycoprotein I in its interaction with cardiolipin.
    Hagihara Y; Goto Y; Kato H; Yoshimura T
    J Biochem; 1995 Jul; 118(1):129-36. PubMed ID: 8537301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human beta2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system.
    Igarashi M; Matsuura E; Igarashi Y; Nagae H; Ichikawa K; Triplett DA; Koike T
    Blood; 1996 Apr; 87(8):3262-70. PubMed ID: 8605342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of anticardiolipin antibodies to protein C via beta2-glycoprotein I (beta2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system.
    Atsumi T; Khamashta MA; Amengual O; Donohoe S; Mackie I; Ichikawa K; Koike T; Hughes GR
    Clin Exp Immunol; 1998 May; 112(2):325-33. PubMed ID: 9649198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant domain V of β2-glycoprotein I inhibits the formation of a 7-ketocholesteryl-9-carboxynonanoate and β2-glycoprotein I complex.
    Zhang Y; Li W; Chi Y; Wang R; Wang D; Zhang F; Liu Z; Matsuura E; Liu Q
    J Biochem; 2011 Jan; 149(1):35-42. PubMed ID: 20876187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant domain V of β2-glycoprotein I inhibits the formation of atherogenic oxLDL/β2-glycoprotein I complexes.
    Li J; Chi Y; Liu S; Wang L; Wang R; Han X; Matsuura E; Liu Q
    J Clin Immunol; 2014 Aug; 34(6):669-76. PubMed ID: 24970589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
    Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T
    Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
    Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y
    Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalent attachment of functionalized cardiolipin on a biosensor gold surface allows repetitive measurements of anticardiolipin antibodies in serum.
    Schlichtiger A; Baier C; Yin MX; Holmes AB; Maruyama M; Strasser R; Rant U; Thaler M; Luppa PB
    Anal Bioanal Chem; 2013 Jan; 405(1):275-85. PubMed ID: 23090649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitopes on beta2-GPI recognized by anticardiolipin antibodies.
    Koike T; Ichikawa K; Kasahara H; Atsumi T; Tsutsumi A; Matsuura E
    Lupus; 1998; 7 Suppl 2():S14-7. PubMed ID: 9814665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro.
    Nojima J; Kuratsune H; Suehisa E; Kitani T; Iwatani Y; Kanakura Y
    Thromb Haemost; 2004 May; 91(5):967-76. PubMed ID: 15116258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation.
    Rahgozar S; Yang Q; Giannakopoulos B; Yan X; Miyakis S; Krilis SA
    Arthritis Rheum; 2007 Feb; 56(2):605-13. PubMed ID: 17265495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibodies in arterial thrombosis.
    Koike T
    Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic structures recognized by anti-beta2-glycoprotein I auto-antibodies.
    Kasahara H; Matsuura E; Kaihara K; Yamamoto D; Kobayashi K; Inagaki J; Ichikawa K; Tsutsumi A; Yasuda S; Atsumi T; Yasuda T; Koike T
    Int Immunol; 2005 Dec; 17(12):1533-42. PubMed ID: 16221723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change.
    de Laat B; Derksen RH; van Lummel M; Pennings MT; de Groot PG
    Blood; 2006 Mar; 107(5):1916-24. PubMed ID: 16269621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome.
    Guerin J; Sheng Y; Reddel S; Iverson GM; Chapman MG; Krilis SA
    J Biol Chem; 2002 Jan; 277(4):2644-9. PubMed ID: 11711550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of β2-glycoprotein I (β2GPI) carbohydrate chains in the reactivity of anti-β2GPI antibodies from patients with primary antiphospholipid syndrome and in the activation and differentiation of U937 cells.
    Hernández-Ramírez DF; Olivares-Martínez E; Núñez-Álvarez CA; Chavelas EA; García-Hernández E; Gómez-Hernández G; Llorente L; Cabral AR
    Biochem Biophys Res Commun; 2014 Oct; 453(1):94-100. PubMed ID: 25256745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with beta2-glycoprotein-I and anti-beta2-glycoprotein-I antibodies.
    Ambrozic A; Cucnik S; Tomsic N; Urbanija J; Lokar M; Babnik B; Rozman B; Iglic A; Kralj-Iglic V
    Autoimmun Rev; 2006 Nov; 6(1):10-5. PubMed ID: 17110310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.